Evidence map›Paper›PMID 39955269›Full record

ArticleNature communications2025

Sox9 inhibits Activin A to promote biliary maturation and branching morphogenesis.

Hannah R Hrncir, Brianna Goodloe, Sergei Bombin, Connor B Hogan, Othmane Jadi, Adam D Gracz

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Co-repression ofbioRxiv : the preprint server for biology · 2026
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

  • Update of
    2024
5 · Who and what money

Authors and funding

6 authors.

Hannah R HrncirDepartment of Medicine, Division of Digestive Diseases, Emory University, Atlanta, GA, USA.
Brianna GoodloeDepartment of Medicine, Division of Digestive Diseases, Emory University, Atlanta, GA, USA.ORCID http://orcid.org/0009-0005-4852-3745
Sergei BombinDepartment of Medicine, Division of Digestive Diseases, Emory University, Atlanta, GA, USA.
Connor B HoganDepartment of Medicine, Division of Digestive Diseases, Emory University, Atlanta, GA, USA.
Othmane JadiSchool of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Adam D GraczDepartment of Medicine, Division of Digestive Diseases, Emory University, Atlanta, GA, USA. agracz@emory.edu.ORCID http://orcid.org/0000-0003-1298-568X

Funding

Virology Research Program (Program 4)P30CA016086 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI David Darr · 1985 to 2026
$201.5M
Yerkes National Primate Research Center Role of type-I IFN in regulating COVID-19 induced inflammation and pathogenesisP51OD011132 · OD · EMORY UNIVERSITY · PI Joon Sup Lee · 2012 to 2026
$167.0M
Winship Cancer Institute Cancer Center Support GrantP30CA138292 · NCI · EMORY UNIVERSITY · PI Suresh S Ramalingam · 2009 to 2026
$47.5M
Training Program in Biochemistry, Cell and Molecular BiologyT32GM135060 · NIGMS · EMORY UNIVERSITY · PI Lawrence H. Boise, ANITA H. CORBETT · 2020 to 2026
$2.8M
Regulation of intestinal stem cell state by ID3R35GM142503 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Adam David Gracz · 2021 to 2026
$2.5M
Genetic regulation of ductular reaction in liver injury and regenerationR01DK132653 · NIDDK · EMORY UNIVERSITY · PI SRINIVASAN, SHANTHI K · 2022 to 2025
$1.6M
Cleared Tissue Large FOV Microscope RequestS10OD032320 · OD · EMORY UNIVERSITY · PI MARCUS, ADAM I. · 2022 to 2022
$308k
Establishing Sox9 as a regulator of intrahepatic bile duct development and regenerationF31DK134199 · NIDDK · EMORY UNIVERSITY · PI HRNCIR, HANNAH ROSE · 2022 to 2024
$143k
NCI NIH HHS P30 CA016086NCI NIH HHS P30 CA138292NIDDK NIH HHS F31 DK134199NIDDK NIH HHS R01 DK132653NIGMS NIH HHS R35 GM142503NIGMS NIH HHS T32 GM135060NIH HHS P51 OD011132NIH HHS S10 OD032320U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (National Institute of Diabetes & Digestive & Kidney Diseases) F31DK134199U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (National Institute of Diabetes & Digestive & Kidney Diseases) R01DK132653
6 · The paper itself

Abstract

Intrahepatic bile duct (IHBD) development produces a morphologically heterogeneous network of large "ducts" and small "ductules" by adulthood. IHBD formation is closely linked to developmental specification of biliary epithelial cells (BECs) starting as early as E13.5, but mechanisms regulating differential IHBD morphology remain poorly understood. Here, we show that duct and ductule development has distinct genetic requirements, with Sox9 required to form the developmental precursors to peripheral ductules in adult livers. By optimizing large-volume IHBD imaging, we find that IHBDs emerge as a homogeneous webbed structure by E15.5 and undergo morphological maturation through 2 weeks of age. Developmental knockout of Sox9 leads to decreased postnatal branching morphogenesis, resulting in adult IHBDs with normal ducts but significantly fewer ductules. In the absence of Sox9, BECs fail to mature and exhibit elevated TGF-β signaling and Activin A. Exogenous Activin A is sufficient to induce developmental gene expression and morphological defects in wild-type BEC organoids, while early postnatal inhibition of Activin A in vivo rescues IHBD morphogenesis in the absence of Sox9. Our data demonstrate that proper IHBD architecture relies on inhibition of Activin A by Sox9 to promote ductule morphogenesis, defining regulatory mechanisms underlying morphological heterogeneity.

Indexed as

ActivinsBile Ducts, IntrahepaticMorphogenesisSOX9 Transcription FactorAnimalsEpithelial CellsFemaleGene Expression Regulation, DevelopmentalLiverMaleMiceMice, KnockoutOrganoidsSignal TransductionTransforming Growth Factor betaactivin AActivinsSox9 protein, mouseSOX9 Transcription FactorTransforming Growth Factor beta

Identifiers

PMID39955269
PMCPMC11830073

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.